Xiamen Amoytop Biotech Stock Beneish M Score

688278 Stock   76.15  2.00  2.56%   
This module uses fundamental data of Xiamen Amoytop to approximate the value of its Beneish M Score. Xiamen Amoytop M Score tells investors if the company management is likely to be manipulating earnings. The score is calculated using eight financial indicators that are adjusted by a specific multiplier. Please note, the M Score is a probabilistic model and cannot detect companies that manipulate their earnings with 100% accuracy. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Xiamen Amoytop Biotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
  
As of March 16, 2025, Short and Long Term Debt is expected to decline to about 3.6 M.
At this time, Xiamen Amoytop's M Score is inapplicable. The earnings manipulation may begin if Xiamen Amoytop's top management creates an artificial sense of financial success, forcing the stock price to be traded at a high price-earnings multiple than it should be. In general, excessive earnings management by Xiamen Amoytop executives may lead to removing some of the operating profits from subsequent periods to inflate earnings in the following periods. This way, the manipulation of Xiamen Amoytop's earnings can lead to misrepresentations of actual financial condition, taking the otherwise loyal stakeholders on to the path of questionable ethical practices and plain fraud.
-2.32
Beneish M Score - Inapplicable
Elasticity of Receivables

1.0

Focus
Asset Quality

1.09

Focus
Expense Coverage

0.68

Focus
Gross Margin Strengs

N/A

Focus
Accruals Factor

0.68

Focus
Depreciation Resistance

N/A

Focus
Net Sales Growth

1.05

Focus
Financial Leverage Condition

N/A

Focus

Xiamen Amoytop Beneish M-Score Indicator Trends

The cure to earnings manipulation is the transparency of financial reporting. It will typically remove the temptation of the top executives to inflate earnings (i.e., to promote the idea of 'winning at any cost'). Because a healthy internal audit department can enhance transparency, the board should promote the auditors' access to all the record-keeping systems across the enterprise. For example, if Xiamen Amoytop's auditors report directly to the board (not management), the managers will be reluctant to manipulate simply due to the fear of punishment. On the other hand, the auditors will be free to investigate the ledgers properly because they know that the board has their back.
Current ValueLast YearChange From Last Year 10 Year Trend
Net Receivables528.7 M503.5 M
Sufficiently Up
Slightly volatile
Total Revenue2.5 B2.4 B
Sufficiently Up
Slightly volatile
Total Assets2.8 B2.7 B
Sufficiently Up
Slightly volatile
Total Current Assets1.6 B1.5 B
Sufficiently Up
Slightly volatile
Non Current Assets Total1.2 B1.2 B
Sufficiently Up
Slightly volatile
Property Plant Equipment119.2 M221.9 M
Way Down
Slightly volatile
Selling General Administrative491.3 M689.7 M
Way Down
Slightly volatile
Total Current Liabilities487.4 M464.2 M
Sufficiently Up
Slightly volatile
Non Current Liabilities Total76.2 M87.4 M
Fairly Down
Slightly volatile
Operating Income826.4 M787.1 M
Sufficiently Up
Slightly volatile
Short Term Investments272.9 M295.6 M
Significantly Down
Very volatile

Xiamen Amoytop Biotech Beneish M-Score Driver Matrix

One of the toughest challenges investors face today is learning how to quickly synthesize historical financial statements and information provided by the company, SEC reporting, and various external parties in order to detect the potential manipulation of earnings. Understanding the correlation between Xiamen Amoytop's different financial indicators related to revenue, expenses, operating profit, and net earnings helps investors identify and prioritize their investing strategies towards Xiamen Amoytop in a much-optimized way. Analyzing correlations between earnings drivers directly associated with dollar figures is the most effective way to find Xiamen Amoytop's degree of accounting gimmicks and manipulations.

About Xiamen Amoytop Beneish M Score

M-Score is one of many grading techniques for value stocks. It was developed by Professor M. Daniel Beneish of the Kelley School of Business at Indiana University and published in 1999 under the paper titled The Detection of Earnings Manipulation. The Beneish score is a multi-factor model that utilizes financial identifiers to compile eight variables used to classify whether a company has manipulated its reported earnings. The variables are built from the officially filed financial statements to create a final score call 'M Score.' The score helps to identify companies that are likely to manipulate their profits if they show deteriorating gross margins, operating expenses, and leverage against growing revenue.

Reconciled Depreciation

45.44 Million

At present, Xiamen Amoytop's Reconciled Depreciation is projected to increase significantly based on the last few years of reporting.

Xiamen Amoytop Earnings Manipulation Drivers

Although earnings manipulation is typically not the result of intentional misconduct by the c-level executives, it is still a widespread practice by the senior management of public companies such as Xiamen Amoytop. It is usually done by a series of misrepresentations of various accounting rules and operating activities across multiple financial cycles. The best way to spot the manipulation is to examine the historical financial statement to find inconsistencies in earning reports to find trends in assets or liabilities that are not sustainable in the future.
202020212022202320242025 (projected)
Net Receivables162.9M186.4M217.1M437.8M503.5M528.7M
Total Revenue793.9M1.1B1.5B2.1B2.4B2.5B
Total Assets1.2B1.4B1.8B2.4B2.7B2.8B
Total Current Assets772.8M834.4M955.6M1.3B1.5B1.6B
Non Current Assets Total419.9M589.8M812.9M1.0B1.2B1.2B
Property Plant Equipment74.1M96.2M126.7M192.9M221.9M119.2M
Selling General Administrative446.8M620.4M736.5M599.8M689.7M491.3M
Total Current Liabilities114.9M177.2M267.9M403.7M464.2M487.4M
Non Current Liabilities Total77.4M85.7M93.1M76.0M87.4M76.2M
Operating Income153.6M239.7M398.1M684.4M787.1M826.4M
Total Cash From Operating Activities92.6M234.8M363.2M512.1M588.9M618.4M

About Xiamen Amoytop Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Xiamen Amoytop Biotech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Xiamen Amoytop using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Xiamen Amoytop Biotech based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

Other Information on Investing in Xiamen Stock

Xiamen Amoytop financial ratios help investors to determine whether Xiamen Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Xiamen with respect to the benefits of owning Xiamen Amoytop security.